Brand-name injectable options Ozempic (semaglutide for type 2 diabetes) Available doses: 0.25 mg, 0.5 mg, 1 mg, 2 mg weekly
People who felt their appetite starting to creep back toward the end of month one often find that the first dose increase pushes it right back down
In the brain, GLP-1 receptor activation affects areas that regulate appetite and satiety, leading to reduced hunger and increased feelings of fullness
Studies show these drugs can lead to significant weight loss
The fatigue during early semaglutide use more likely results from caloric restriction, changes in eating patterns, and the medication adjusting appetite and satiety signals
No insurance is required, and the medication is HSA/FSA eligible, making the transition financially accessible for most patients